Search results
CVS COVID-19 Vaccine Near Ashburn VA
www.cvs.comPharmacy LocationBy appointment only44835 Russel Branch Parkway(571) 223-000623684 Strickland Drive(571) 367-603921170 Ashby Ponds Blvd(571) 293-716943930 Farmwell Hunt Plaza(703) 724-7582Children aged ≥8 years (nasopharynx, urogenital, and rectal) azithromycin 1 gm orally in a single dose OR doxycycline 100 mg orally 2x/day for 7 days Neonates:5 ophthalmia and pneumonia erythromycin base 50 mg/kg body weight/day orally, divided into 4 doses daily for 14 days OR ethylsuccinate 50 mg/kg body weight/day orally,
- 390KB
- 24
- Cervical Diaphragms
- Multipurpose Prevention Technologies
- Topical Microbicides and Spermicides
- NonBarrier Contraception, Female Surgical Sterilization, and Hysterectomy
- Emergency Contraception
- Male Circumcision
- Pre-Exposure Prophylaxis For HIV
- Pre-Exposure Prophylaxis For STIs
- Postexposure Prophylaxis For HIV and STIs
In observational studies, diaphragm use has been demonstrated to protect against cervical gonorrhea, chlamydia, and trichomoniasis (34). However, a trial examining the effect of a diaphragm plus lubricant on HIV acquisition among women in Africa reported no additional protective effect when compared with the use of male condoms alone. Likewise, no ...
Methods that combine STI and HIV prevention with pregnancy prevention are known as multipurpose prevention technologies (MPTs) (37) (https://www.who.int/ reproductivehealth/topics/linkages/mpts/en). Internal and external condoms are both examples of MPTs because they are effective prevention measures when used correctly for STI and HIV transmission...
Nonspecific topical microbicides are ineffective for preventing HIV infection (40–45). Tenofovir gel has been studied for prevention of herpes simplex virus 2 (HSV-2) and HIV infections (46,47). Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).Vaginal rings containing dapivirine h...
Contraceptive methods that are not mechanical barriers offer no protection against HIV or other STIs. The ECHO study observed no differences in HIV incidence rates among women randomly assigned to DMPA, levonorgestrel implant, or copper-containing IUD contraceptive methods (38). A systematic review of epidemiologic evidence reported that the majori...
Unprotected intercourse exposes women to risks for STIs and unplanned pregnancy. Providers should offer counseling about the option of emergency contraception if pregnancy is not desired. Options for emergency contraception in the United States include copper-containing IUDs and emergency contraceptive pills (ECPs) (58,59). More information is avai...
Male circumcision reduces the risk for HIV infection and certain STIs among heterosexual men. Three randomized, controlled trials performed in regions of sub-Saharan Africa, where generalized HIV epidemics involving predominantly heterosexual transmission were occurring, demonstrated that male circumcision reduces the risk for HIV acquisition among...
Daily oral antiretroviral PrEP with a fixed-dose combination of emtricitabine (FTC) and either tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF) have demonstrated safety (74) and a substantial reduction in the rate of HIV acquisition for MSM (75). TDF/FTC has demonstrated safety and efficacy for mixed-status heterosexual couples (7...
Providing HSV treatment to persons with HIV and HSV infection has not demonstrated benefit in reducing HIV acquisition among uninfected partners. A large randomized controlled trial evaluated mixed-status heterosexual couples among the partners with HIV infection who also were seropositive for HSV-2 (88). Use of acyclovir had no effect on HIV trans...
Guidelines for using PEP aimed at preventing HIV and other STIs as a result of sexual exposure are available at https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf. Sexually active persons seeking HIV PEP should be evaluated for PrEP after completing their PEP course and testing negative for HIV. HIV PEP is also discussed elsew...
Randomized controlled trials on the use of doxycycline as PEP to reduce bacterial STIs. Reduced risk of acquiring chlamydia and syphilis by 70% (HR 0.30 (95% CI 0.13-0.70) and 73% (HR 0.27 (95% CI 0.07-0.98), respectively. Relative risk of an STI infection per quarter.
Sep 29, 2023 · Print. Efficacy of Doxycycline as PEP to Prevent Bacterial STIs. Doxycycline Individual Level Harms – Antimicrobial Resistance. Doxycycline Use and Adverse Events. Last Reviewed: September 29, 2023. Source: Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention.
Jul 7, 2021 · Abstract. Editorial for Sexually Transmitted Diseases (STD20–495): Interest, concerns, and attitudes among men who have sex with men and healthcare providers toward prophylactic use of doxycycline against Chlamydia trachomatis infections and syphilis.
- Connie Celum, Anne F Luetkemeyer
- 2021
Apr 6, 2023 · The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.
Mar 24, 2021 · Recommended Regimens: Azithromycin 1 g orally in a single dose OR Doxycycline 100 mg orally twice per day for 7 days (Azithromycin in pregnancy)